https://www.selleckchem.com/products/FTY720.html
l conditions (e.g., diet and colony management).[This corrects the article DOI 10.3389/fneur.2020.00802.].Approximately one third of epilepsy patients do not become seizure free with antiseizure medications. This treatment gap motivates research for new therapeutic options, such as cannabidiol (CBD). CBD differs from other cannabis derivatives because of its consistent efficacy and lack of a psychoactive effect. CBD can be recommended as adjunctive therapy in patients with Dravet and Lennox-Gastaut syndromes. The most common adverse effe
Like
Comment
Share
